Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease

Toda Y, Iwatsubo T, Nakamura Y, Matsuda N, Miyata M, Jin M, Chen T, Kuribayashi K, Tian Y, Hughes R, Yamamoto J, Muralidharan KK, Rubel C, Hutchison RM, Budd Haeberlein S.

J Prev Alzheimers Dis. 2024;11(5):1260-1269. doi: 10.14283/jpad.2024.106.

Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome

Carmona-Iragui M, O'Connor A, Llibre-Guerra J, Lao P, Ashton NJ, Fortea J, Sánchez-Valle R.

EBioMedicine. 2024 Oct;108:105327. doi: 10.1016/j.ebiom.2024.105327. Epub 2024 Oct 3.

Argentina-Alzheimer's Disease Neuroimaging Initiative: pioneering Alzheimer's Research in Latin America and its Implications for Regional Advancement

Cubas Guillen JF, Chrem Méndez P, Surace E, Martin ME, Clarens F, Russo J, Harris P, Egido N, Tapajoz F, Chaves H, Vázquez S, Martinetto H, Campos J, Calandri IL, Sevlever G, Allegri RF.

Alzheimers Dement. 2024 Nov;20(11):8153-8161. doi: 10.1002/alz.14285. Epub 2024 Oct 6.

Use of biomarkers in the diagnosis of Alzheimer's disease in adults with intellectual disability

McFeely A, O'Connor A, Kennelly SP.

Lancet Healthy Longev. 2024 Oct;5(10):100639. doi: 10.1016/j.lanhl.2024.100639. Epub 2024 Oct 3.

Decoding paradoxical links of cytokine markers in cognition: Cross talk between physiology, inflammaging, and Alzheimer's disease- related cognitive decline

Khan H, Naseem T, Kaushik P, Narang J, Khan R, Panwar S, Parvez S.

Ageing Res Rev. 2024 Nov;101:102535. doi: 10.1016/j.arr.2024.102535. Epub 2024 Oct 6.

Cognivue Clarity characterizes mild cognitive impairment and Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study

Galvin JE, Kleiman MJ, Estes PW, Harris HM, Fung E.

Sci Rep. 2024 Oct 18;14(1):24519. doi: 10.1038/s41598-024-75304-5.

Timing of Alzheimer's disease biomarker progressions: A two-decade observational study from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Schaap T, Thropp P, Tosun D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Dec;20(12):9060-9067. doi: 10.1002/alz.14306. Epub 2024 Oct 21.

Cerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions

Maillard P, Fletcher E, Carmichael O, Schwarz C, Seiler S, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Dec;20(12):8953-8968. doi: 10.1002/alz.14358. Epub 2024 Nov 13.

Agreement between Cerebrospinal Fluid Biomarkers, Brain 18-Fluorodeoxyglucose PET, and Clinical Diagnosis in Older Adults with Cognitive Impairment

Alberto J MA, Karen G LD, Rodrigo HR, Juan de D RC, Sara G YC, Sara G AN.

Rev Invest Clin. 2024;76(5):230-237. doi: 10.24875/RIC.24000161.

Blood Cathepsins on the Risk of Alzheimer's Disease and Related Pathological Biomarkers: Results from Observational Cohort and Mendelian Randomization Study

Qian XH, Ding GY, Chen SY, Liu XL, Zhang M, Tang HD.

J Prev Alzheimers Dis. 2024;11(6):1834-1842. doi: 10.14283/jpad.2024.107.

Neuroinflammatory Biomarkers in Alzheimer's Disease: From Pathophysiology to Clinical Implications

Roveta F, Bonino L, Piella EM, Rainero I, Rubino E.

Int J Mol Sci. 2024 Nov 6;25(22):11941. doi: 10.3390/ijms252211941.

Medication Exposure and Risk of Dementia and Alzheimer's Disease

Sharma N, An SSA, Kim SY.

Int J Mol Sci. 2024 Nov 29;25(23):12850. doi: 10.3390/ijms252312850.

Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis

Lombardi G, Pancani S, Manca R, Mitolo M, Baiardi S, Massa F, Coppola L, Franzese M, Nicolai E, Guerini FR, Mancuso R, Agliardi C, Agostini S, Pardini M, Virgili G, Sorbi S, Parchi P, Nacmias B, Venneri A.

Int J Mol Sci. 2024 Nov 30;25(23):12916. doi: 10.3390/ijms252312916.

Cognitive impairment in bipolar disorder in comparison to mild cognitive impairment and dementia: a systematic review

Simjanoski M, McIntyre A, Kapczinski F, Cardoso TA.

Trends Psychiatry Psychother. 2023 Feb 20;44:e20210300. doi: 10.47626/2237-6089-2021-0300.

Acupressure and Dementia: A Review of Current Evidence

Liang Ooi S, Drew G, Cheon Pak S.

Altern Ther Health Med. 2023 Oct;29(7):18-29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias